Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Recombinant Tropomyosin- and Hemocyanin-Specific IgE in Children With Suspected Shrimp Allergy [NA]

View source ↗

Summary

Clinical trial evaluating recombinant tropomyosin- and hemocyanin-specific IgE in children with suspected shrimp allergy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City | Conditions: Food Hypersensitivity, Shellfish Allergy | NA | Status: NOT_YET_RECRUITING